| scholarly article | Q13442814 |
| P2093 | author name string | Yi Sun | |
| Hong Zhou | |||
| Lin Weng | |||
| Quanbin Zhang | |||
| Baoxue Yang | |||
| Dali Luo | |||
| Jihui Chen | |||
| Yingli Jia | |||
| Wentong Cui | |||
| P2860 | cites work | Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition | Q24305416 |
| MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT | Q26851458 | ||
| Role of the TGF-β/BMP-7/Smad pathways in renal diseases | Q28278757 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy | Q33808925 | ||
| Molecular basis of renal fibrosis | Q34125332 | ||
| Low molecular weight fucoidan against renal ischemia-reperfusion injury via inhibition of the MAPK signaling pathway | Q34589918 | ||
| Low-molecular-weight fucoidan protects endothelial function and ameliorates basal hypertension in diabetic Goto-Kakizaki rats | Q35116260 | ||
| The role of epithelial-to-mesenchymal transition in renal fibrosis | Q35643525 | ||
| TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing | Q35841836 | ||
| Transcriptional regulation of cadherins during development and carcinogenesis. | Q35878878 | ||
| Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta | Q36232185 | ||
| Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways | Q36313178 | ||
| Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition | Q36321284 | ||
| Fucoidan partly prevents CCl4-induced liver fibrosis | Q36482392 | ||
| Signaling cross-talk between TGF-beta/BMP and other pathways | Q37323342 | ||
| Transcriptional regulation of cell polarity in EMT and cancer | Q37333606 | ||
| TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. | Q37627056 | ||
| Diabetic nephropathy in 2010: Alleviating the burden of diabetic nephropathy | Q37833489 | ||
| Fibroblasts and myofibroblasts in renal fibrosis | Q37847632 | ||
| Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease | Q38027100 | ||
| Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. | Q39218826 | ||
| TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition | Q39418101 | ||
| Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition | Q40120833 | ||
| Effects of fucoidan on chronic renal failure in rats | Q44515101 | ||
| Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum | Q46951463 | ||
| Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor | Q47226139 | ||
| Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes | Q47236254 | ||
| The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. | Q48552318 | ||
| Effect of fucoidan administration on insulin secretion and insulin resistance in overweight or obese adults. | Q51325986 | ||
| Fucoidan regulate blood glucose homeostasis in C57BL/KSJ m+/+db and C57BL/KSJ db/db mice. | Q51356882 | ||
| Connective Tissue Growth Factor Expressed in Tubular Epithelium Plays a Pivotal Role in Renal Fibrogenesis | Q57691320 | ||
| Development of diabetes in the non-obese NIDDM rat (GK rat) | Q70264384 | ||
| The emerging role of transforming growth factor-beta in kidney diseases | Q72043105 | ||
| Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus | Q73396325 | ||
| Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease | Q83158832 | ||
| Suppression by fucoidan of liver fibrogenesis via the TGF-β/Smad pathway in protecting against oxidative stress | Q84150886 | ||
| Mechanisms of tubulointerstitial fibrosis | Q85074102 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 1553-1563 | |
| P577 | publication date | 2015-09-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes | |
| P478 | volume | 7 |
| Q33612287 | Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial |
| Q26739976 | Fucoidans in Nanomedicine |
| Q37193130 | Low molecular weight fucoidan protects renal tubular cells from injury induced by albumin overload |
| Q64111682 | Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-β1-induced epithelial-mesenchymal transition through ERK pathway |
| Q41066153 | Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression. |
| Q89975396 | Protective Effect of Low-Molecular-Weight Fucoidan on Radiation-Induced Fibrosis Through TGF-β1/Smad Pathway-Mediated Inhibition of Collagen I Accumulation |
Search more.